Innogen Pharma Resubmits Hong Kong IPO Application With Promising Diabetes Drug
China-based Guangzhou Innogen Pharmaceutical Group Co., Ltd. has resubmitted its application for a main board...
Deals
Harrow Signs Licensing Deal for Formosa’s Byqlovi in US Market
US-based ophthalmic pharmaceutical company Harrow (NASDAQ: HROW) announced a licensing agreement with Taiwan-based Formosa Pharmaceuticals...
Sanyou Biopharma Partners with Medicovestor to Advance Next-Gen ADCs
China-based Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. announced a strategic partnership with US-headquartered Medicovestor, Inc. to...
Sinopep Allsino Partners with Vazyme to Advance Synthetic Biology
China-based Jiangsu Sinopep Allsino Biopharmaceutical Co., Ltd. (SHA: 688076) announced a strategic partnership with compatriot...
CIRC and Qianlong International Collaborate to Advance BNCT and Nuclear Medicine
China Isotope & Radiation Corporation (CIRC; HKG: 1763) and Hong Kong-based Qianlong International Holdings Ltd....
Lifetech Scientific Plans RMB 150 Million Investment in AffectOR MedTech
China-based Lifetech Scientific Corporation (HKG: 1302) announced plans to invest RMB 150 million (USD 21...
OBI Pharma Partners with TegMine to Develop Antibody-Drug Conjugates
Taiwan-based OBI Pharma announced a collaboration with San Francisco-based TegMine Therapeutics, Inc. to develop antibody-drug...
Kindstar Global Partners with Biostate AI to Advance Precision Medicine
China-based Kindstar Global (HKG: 9960) announced the establishment of a joint venture (JV) with US-headquartered...
Zelgen Bio Collaborates with Merck KGaA for rhTSH Promotion in China
China’s Suzhou Zelgen Biopharmaceuticals Co., Ltd (SHA: 688266) announced a collaboration agreement with Merck KGaA...
Lancet Robotics Secures Series A+ Funding for Surgical Robot Development
Shenzhen-based Lancet Robotics, a developer of orthopedic joint replacement surgical robots, has reportedly secured “tens...
Bayer’s Vividion Gains Global Rights to WRN Inhibitor VVD-214
German pharmaceutical giant Bayer AG (ETR: BAYN) announced that its wholly owned subsidiary Vividion Therapeutics,...
Nanjing Leads Biolabs Files for Hong Kong IPO Amid Product Pipeline Progress
China-based Nanjing Leads Biolabs Co., Ltd., a clinical-stage biotech company focusing on oncology and autoimmune...
Qure Biotechnology Secures RMB 100 Million Series C1 Financing
China-based Qure Biotechnology (Shanghai) Co., Ltd. announced the completion of a Series C1 financing round...
Shanghai OPM Biosciences Plans Acqusition of PharmaLegacy Labs for RMB 1.45 Billion
Shanghai OPM Biosciences Co., Ltd (SHA: 688293), a China-based cell culture-focused Contract Development and Manufacturing...
Intragrand Pharma Licenses Lenamilast to Transpire Bio for Global Development
China-based Suzhou Intragrand Pharma has entered into a licensing agreement with U.S.-headquartered Transpire Bio Inc....
Consun Pharma Partners with DP Technology to Accelerate AI-Driven Kidney Disease Drug R&D
China-based Consun Pharmaceutical Group Ltd (HKG: 1681) announced a strategic partnership with compatriot firm DP...
Shanghai Pharma Partners with Chugai Pharma China to Enhance Bone Health Products
China’s Shanghai Pharmaceuticals Holding Co., Ltd. (HKG: 2607, SHA: 601607; SPH) has established a partnership...
Genrix Bio Partners with Cullinan Therapeutics for GR1803 License
China-based Chongqing Genrix Biopharmaceutical Co., Ltd (SHA: 688443) announced a licensing agreement with Cullinan Therapeutics,...
SciBrunch Therapeutics Secures RMB 200 Million in Angel Financing Round
Shanghai-based SciBrunch Therapeutics, a developer of small molecule anti-tumor drugs, has reportedly secured over RMB...
Sichuan Kelun-Biotech Raises $250M in Hong Kong’s Largest Follow-On Offering
China-based Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG: 6990) announced the successful placement of 5,918,000 new...